HOXA-AS2 and acute lymphoblastic leukemia: Zhao et al demonstrated HOXA‐AS2 could up‐regulate HOXA3, thereby activating the EGFR/Ras/Raf/MEK/ERK signalling pathway and decreased glucocorticoid sensitivity in acute lymphoblastic leukaemia.17